Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes".
48
Introduction 49 50 Approximately 250,000 episodes of bloodstream infections occur in the United 51
States annually. 1 Bloodstream infections have an overall mortality rate of 18%, making 52 them one of the leading causes of death in the U.S. 2 Over the last two decades, Gram-53 negative bacteria have become a less frequent cause of bloodstream infections, 3 since the 54 increased use of indwelling vascular devices has resulted in a larger proportion of Gram-55 positive bacteraemias. 1 However, there is evidence that Gram-negative bacteraemias are 56 increasing once again. 4 Antibiotic resistance among Gram-negative bacteria is also 57 increasing. 5 There has been limited development of new antibiotics with Gram-negative 58 activity, 6,7 which has made the treatment of Gram-negative bacteraemia more difficult. 59
Previous studies of bloodstream infections have focused primarily on ICU-60 acquired infections, because critically ill patients represent a well-defined and highly 61 vulnerable population. 8, 9 However, bloodstream infections among hospitalized patients 62 outside the ICU account for at least half of all nosocomial bloodstream infections. 10 63 These infections in non-ICU patients have rarely been investigated separately. 11, 12 This is 64 presumably because they were believed to be associated with less morbidity and 65 mortality than in ICU patients, and also because the distribution of non-ICU patients in a 66 hospital requires more workforce to conduct a prospective study. Little data are available 67 on the demographic characteristics of non-ICU patients with Gram-negative bacteraemia, 68
and their clinical outcomes. 69
Several studies have demonstrated that inadequate empirical antibiotic treatment 70 of bacteraemia is associated with poor outcome. [13] [14] [15] [16] These studies have mainly focused 71 on ICU patients or have been carried out in diverse populations. 17 Inadequate empirical 72 treatment was reported in 23-30% of cases in previous studies. However, a 53% rate of 73 inadequate treatment was reported in infections due to antibiotic-resistant organisms. 18 If 74 similar rates of inadequate treatment exist in non-ICU patients, empirical antibiotic 75 prescribing practices would need to be re-examined. 76
In this study, we describe the epidemiology of Gram-negative bacteraemia in non-77 
Inclusion and exclusion criteria 96
All adult patients admitted to non-ICU wards who presented with or developed Gram-97 negative bacteraemia (≥1 positive blood culture) were included. Polymicrobial infections 98 were also included if at least one Gram-negative organism was present. Subsequent 99 episodes of bacteraemia in study patients were excluded from the analysis. Patients who 100 were bacteraemic as an outpatient (in clinics or in the emergency department) and who 101 were discharged to home before the results of the culture were known were excluded. We 102 also excluded patients who were initially identified as having a Gram-negative laboratory identification (n=4). susceptibilities. 17 We analyzed inadequate treatment within 24 hours of blood culture 132 sampling, since this definition has been used in the largest number of studies. If antibiotic 133 susceptibility testing was not performed, we decided on a case-by-case basis whether 134 treatment could be considered adequate, based on the antibiogram for that particular 135 organism at Barnes-Jewish Hospital. Multi-drug resistance was defined using previously 136 published criteria. 24 137 Sepsis, sepsis-induced hypotension, and multiple organ dysfunction syndrome were 138 defined using established criteria. 25 In our institution, the microbiology laboratory notifies the clinician when a blood culture 151 becomes positive. Following notification, the clinician is responsible for reviewing 152 subsequent bacterial identification and antimicrobial susceptibility results in the hospital 
The frequency of inadequate antibiotic treatment of Gram-negative bacteraemia 184
The antibiotics with Gram-negative activity that were most frequently prescribed during 185 the 24-hour period after the initial positive blood culture was drawn were cefepime (109; 186 in 43.6% of episodes), ciprofloxacin (57; 22.8%), piperacillin/tazobactam (39; 15.6%), 187 gentamicin (28; 11.2%), ceftriaxone (22; 8.8%), meropenem (9; 3.6%), and 188 ampicillin/sulbactam (5; 2.0%). In 57 cases (22.8%) more than one antibiotic was given 189 in this time period. 190 (48.1%) of cases inadequate treatment was due to failure to administer antibiotics with 192
Gram-negative coverage within 24 hours of the initial positive blood culture, and in 41 193 (51.9%) cases was due to a Gram-negative bacillus that was resistant to the prescribed 194 antibiotic. Within 24 hours after notification of antibiotic susceptibilities, 28 of 197 195 patients (14.2%) were still receiving inadequate antibiotic treatment ( Figure 1 Twenty-eight percent of patients were transferred to the ICU after the bacteraemia 253 had occurred. The in-hospital mortality was substantial (14%), but less than the 24% 254 mortality rate in a Danish population-based study, 28 or in studies of ICU patients with 255
Gram-negative bacteraemia (49-60%). 34, 35 This is likely due to differences in population 256 characteristics including different levels of severity of underlying illnesses, but might 257 also point to differences in the management of sepsis rather than antibiotic treatment. 258 adequacy of antibiotic treatment. 36 This was demonstrated in studies including ICU 261 patients. [13] [14] [15] [16] [17] 23 However, no study has examined the effect of adequate antibiotic 262 treatment on outcomes in non-ICU patients only. We demonstrated rates of inadequate 263 empirical treatment during the first 24 hours after the blood culture (31.6%) similar to the 264 30% -37% reported from other prospective studies. 15, 17 In approximately half of the 265 cases, inadequate treatment was due to failure to administer an antibiotic with Gram-266 negative activity. 267
Hospital-acquired bacteraemia was a risk factor for receiving inadequate 268 empirical antibiotic treatment in our cohort. This has been noted previously, 22, 21, [13] [14] [15] which has been reported before by others. 22,13 E. coli is the most frequent cause of Gram-280 negative bacteraemia and is not as prone to multi-drug resistance as other Gram-negative 281 bacteria, 33 which may explain why it is generally better covered by empirical 282 might be related to mucositis being more often present in a subset of oncology patients, 284 and a tendency to start broad-spectrum antibiotics with Gram-negative activity earlier in 285 this population. 286
287
In our cohort of patients, inadequate empirical treatment was not associated with 288 deterioration of status (transfer to ICU, length of hospital stay, or increased in-hospital 289 mortality). This is in contrast to many studies, in which inadequate treatment was 290 associated with adverse outcomes. [13] [14] [15] [16] [17] 23 However, a few studies that included mixed ICU 291 and non-ICU patient populations have not found this association. 22,21 One possible 292 explanation for our finding is that non-ICU patients in general have a lower severity of 293 illness compared to ICU patients and therefore, the role of the adequate antibiotic 294 treatment may be less crucial. 36 A study underlining this assumption showed that 295 inadequate treatment was more frequently administered in less severely ill patients, with 296 no discernable impact on outcomes. 22 Interventions focused on optimizing treatment for 297 non-ICU patients would likely have the greatest benefit in e.g., neutropenic patients, 298 transplant patients, and patients at risk for Pseudomonas bacteraemia. 299
In addition, we did not find that the use of cefepime for empirical treatment was 300 associated with increased all-cause mortality as a recent meta-analysis has reported. 39 301 302 There are some limitations to our study. First, this is a single, tertiary care hospital 303 and may reflect process issues unique to this facility. In our hospital the clinician is only 304 directly notified by the microbiology laboratory when a blood culture turns positive, but 305 results in the hospital computer system. This may cause delays in starting adequate 307 antibiotic treatment. We also only collected crude mortality, not attributable mortality. 308
The sample size is large for a single-center prospective study but may still be small to 309 detect a difference in outcomes, like Fraser and colleagues reported from a mixed ICU 310 and non-ICU population. 40 311
One of the strengths of this prospective study is the detailed sequential analysis of 312 the adequacy of antibiotic treatment at different time points. Previous studies of the 313 adequacy of treatment have analyzed one specific time frame and not taken into account 314 the dynamic that is inherent in the processing of blood cultures and the notification of 315 results to the treating physician. We also evaluated empirical and definitive therapy 316 separately, and controlled for baseline severity of illness. 41 At our institution, antibiotic 317 treatment is initiated by clinicians from various specialties and levels of professional 318 experience and is therefore diverse, which adds to the generalizability of our findings. 319 320 Our study is the first to prospectively describe the epidemiology of Gram-321 negative bacteraemias in non-ICU patients. The frequency of inadequate empirical 322 antibiotic treatment is similar to data from ICUs. The administration of inadequate 323 treatment did not confer worse patient outcomes. Therefore, while adequate antibiotic 324 therapy is an important factor, our findings suggest that there are other factors that may 325 be more important in determining the prognosis in the non-ICU population. 
